Adaptive Biotechnologies (ADPT) EBT Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) EBT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -36.31% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.36% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -6.75% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 9.91% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 2.67% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 14.73% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -3.23% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 58.91% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -2.56% |
| 10 | Adaptive Biotechnologies | 2.71 Bn | 2.50 Bn | 52.17 Mn | 29.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.74% |
| Dec 31, 2025 | 30.34% |
| Sep 30, 2025 | 30.27% |
| Jun 30, 2025 | 21.09% |
| Mar 31, 2025 | 21.97% |
| Dec 31, 2024 | 18.09% |
| Sep 30, 2024 | 16.93% |
| Jun 30, 2024 | 2.11% |
| Mar 31, 2024 | -5.36% |
| Dec 31, 2023 | -16.93% |
| Sep 30, 2023 | -11.78% |
| Jun 30, 2023 | -10.94% |
| Mar 31, 2023 | -22.06% |
| Dec 31, 2022 | -24.91% |
| Sep 30, 2022 | -48.10% |
| Jun 30, 2022 | -49.27% |
| Mar 31, 2022 | -50.60% |
| Dec 31, 2021 | -66.59% |
| Sep 30, 2021 | -89.02% |
| Jun 30, 2021 | -58.03% |